chr19-10113943-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_002566.5(P2RY11):c.330C>T(p.Thr110Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000928 in 1,602,540 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0021 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00080 ( 8 hom. )
Consequence
P2RY11
NM_002566.5 synonymous
NM_002566.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.50
Genes affected
P2RY11 (HGNC:8540): (purinergic receptor P2Y11) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is coupled to the stimulation of the phosphoinositide and adenylyl cyclase pathways and behaves as a selective purinoceptor. Naturally occuring read-through transcripts, resulting from intergenic splicing between this gene and an immediately upstream gene (PPAN, encoding peter pan homolog), have been found. The PPAN-P2RY11 read-through mRNA is ubiquitously expressed and encodes a fusion protein that shares identity with each individual gene product. [provided by RefSeq, Jul 2008]
PPAN-P2RY11 (HGNC:33526): (PPAN-P2RY11 readthrough) This locus represents naturally occurring read-through transcription between the adjacent PPAN and P2RY11 genes. Alternative splicing results in two transcript variants, one of which encodes a fusion protein that shares sequence identity with each individual gene product. This transcript is found to be ubiquitously expressed and is up-regulated by agents inducing granulocytic differentiation. However, its functional significance in vivo remains unclear. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 19-10113943-C-T is Benign according to our data. Variant chr19-10113943-C-T is described in ClinVar as [Benign]. Clinvar id is 725779.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=2.51 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P2RY11 | NM_002566.5 | c.330C>T | p.Thr110Thr | synonymous_variant | 2/2 | ENST00000321826.5 | NP_002557.2 | |
PPAN-P2RY11 | NM_001040664.3 | c.1590C>T | p.Thr530Thr | synonymous_variant | 13/13 | NP_001035754.1 | ||
PPAN-P2RY11 | NM_001198690.2 | c.*89C>T | 3_prime_UTR_variant | 13/13 | NP_001185619.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P2RY11 | ENST00000321826.5 | c.330C>T | p.Thr110Thr | synonymous_variant | 2/2 | 1 | NM_002566.5 | ENSP00000323872.4 | ||
PPAN-P2RY11 | ENST00000393796.4 | c.1590C>T | p.Thr530Thr | synonymous_variant | 13/13 | 1 | ENSP00000377385.4 | |||
PPAN-P2RY11 | ENST00000428358.5 | c.*89C>T | 3_prime_UTR_variant | 13/13 | 2 | ENSP00000411918.1 |
Frequencies
GnomAD3 genomes AF: 0.00214 AC: 325AN: 152220Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
325
AN:
152220
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00162 AC: 390AN: 240190Hom.: 1 AF XY: 0.00166 AC XY: 217AN XY: 130850
GnomAD3 exomes
AF:
AC:
390
AN:
240190
Hom.:
AF XY:
AC XY:
217
AN XY:
130850
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000801 AC: 1162AN: 1450202Hom.: 8 Cov.: 35 AF XY: 0.000806 AC XY: 582AN XY: 721952
GnomAD4 exome
AF:
AC:
1162
AN:
1450202
Hom.:
Cov.:
35
AF XY:
AC XY:
582
AN XY:
721952
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00213 AC: 325AN: 152338Hom.: 2 Cov.: 33 AF XY: 0.00326 AC XY: 243AN XY: 74486
GnomAD4 genome
AF:
AC:
325
AN:
152338
Hom.:
Cov.:
33
AF XY:
AC XY:
243
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at